Gja1 has been thought to be involved in the pathophysiology of a variety of intestinal epithelial (IEC) barrier diseases, including inflammatory bowel diseases, necrotizing enterocolitis, and enteric infection (Dubina et al. 2002; Velasquez Almonacid et al. 2009). This evidence concerns the gene GJA1 and inflammatory bowel disease.